You are here

Derek N. Bremmer, PharmD, BCPS

Derek N. Bremmer, PharmD, BCPS

Clinical Pharmacy Specialist, Infectious Diseases

Program Director, Infectious Diseases Pharmacy Specialty Residency

Education and Training

PharmD, South Carolina College of Pharmacy, Columbia SC (2013)

PGY1 Pharmacy Practice Residency, UPMC Presbyterian Shadyside, Pittsburgh, PA (2014)

PGY2 Infectious Diseases Residency, The Ohio State University Wexner Medical Center, Columbus, OH (2015)

Professional Memberships

Infectious Disease Society of America

Society of Infectious Diseases Pharmacists

Clinical and Research Interests

Dr. Bremmer’s research interests include clinical outcomes related to antimicrobial stewardship interventions and multi-drug resistant pathogens. 

Selected Publications

  1. Walsh TL, DiSilvio BE, Hammer C, Beg M, Vishwanathan S, Speredelozzi D, Moffa MA, Hu K, Abdulmassih R, Makadia JT, Sandhu R, Naddour M, Chan-Tompkins NH, Trienski TL, Watson C, Obringer TJ, Kuzyck J, Bremmer DN. Impact of procalcitonin guidance with an educational program on management of adults hospitalized with pneumonia. The American Journal of Medicine [In press]
  2. Walsh TL, Moffa MA, Bean HR, Watson C, Bremmer DN. Impact of Antimicrobial Stewardship Program guidance on the management of community-acquired pneumonia in hospitalized adults. Journal of Antimicrobial Stewardship [In press]
  3. Walsh TL, Bremmer DN, Moffa MA, Chan-Tompkins NH, Murillo MA, Chan L, Burkitt MJ, Konopka CI, Watson C, Trienski TL. Effect of antimicrobial stewardship program guidance on the management of uncomplicated skin and soft tissue infections in hospitalized adults. Mayo Clinic Proceedings: Innovations, Quality & Outcomes 2017;1(1):91-99
  4. Bremmer DN, Bookstaver PB, Cairns M, Lindley K, Durkin M, Koon D, Quidley AM. Impact of body mass index and bacterial resistance in osteomyelitis after antibiotic prophylaxis of open lower-extremity fractures. 2017 Surg Infect. 18(3):368-73.
  5. Bremmer DN, Balada-Llasat JM, Goff, DA, Bauer KA. Ceftriaxone Etest non-susceptible methicillin susceptible Staphylococcus aureus time-kill responses. 2017 Diagn Microbiol Infect Dis pii: S0732-8893(17)30075-5.
  6. Walsh TL, DiSilvio BE, Speredelozzi D, Hammer CD, Hu K, Abdulmassih R, Makadia JT, Sandhu R, Naddour M, Vishwanathan S, Chan-Tompkins NH, Trienski TL, Moffa MA, Bremmer DN. Evaluation of management of uncomplicated community-acquired pneumonia: a retrospective assessment. Infectious Diseases in Clinical Practice 2017;25(2):71-75
  7. Walsh TL, Chan L, Konopka CI, Burkitt MJ, Moffa MA, Bremmer DN, Murillo MA, Watson C, Chan-Tompkins NH. Appropriateness of antibiotic management of uncomplicated skin and soft tissue infections in hospitalized adult patients. BMC Infectious Diseases 2016;16(1):721
  8. Bremmer DN, Bauer KA, Pouch SM, Thomas K, Smith D, Goff DA, Pancholi P, Balada-Llasat JM. Correlation of Checkerboard Synergy Testing with Time-kill Analysis and Clinical Outcomes of Extensively Drug Resistant Acinetobacter baumannii Respiratory Infections. 2016. Antimicrob Agents Chemother pii: AAC.00981-16.
  9. Bremmer DN, Nicolau DP, Burcham P, Chunduri A, Shidham G, Bauer KA. Ceftolozane/tazobactam Pharmacokinetics in a Critically Ill Adult Concurrently Receiving Continuous Renal Replacement Therapy. 2016. Pharmacotherapy. 36(5):e30-33.
  10. Bremmer DN, Garavaglia JM, Shields RK. Spontaneous fungal peritonitis: a devastating complication of cirrhosis. 2015 Mycoses 58(7):387-393.
  11. Bremmer DN, Clancy CJ, Press EG, Almaghrabi R, Chen L, Doi Y, Nguyen MH, Shields RK. KPC-Producing Klebsiella pneumoniae Strains That Harbor AAC(6')-Ib Exhibit Intermediate Resistance to Amikacin. 2014. Antimicrob Agents Chemother 58:7597-7600.

Contact Information

Allegheny General Hospital, Department of Pharmacy
320 East North Avenue
Pittsburgh, PA 15212